Silva Francisco 4

4 · BioRestorative Therapies, Inc. · Filed Feb 17, 2023

Form 4

Period: 2023-02-17

VP of Research and Development

Transactions

Award
Stock Option
2023-02-17+106,762→ 106,762 total
Exercise: $2.91Exp: 2033-02-17→ Common Stock (106,762 underlying)

Holdings

Stock Option
Exercise: $5.08Exp: 2031-11-04→ Common Stock (42,059 underlying)
42,059
Common Stock
(indirect: By IRA)
12,136
Stock Option
Exercise: $3000.00Exp: 2023-10-04→ Common Stock (1 underlying)
1
Stock Option
Exercise: $3000.00Exp: 2024-02-18→ Common Stock (3 underlying)
3
Stock Option
Exercise: $3000.00Exp: 2024-10-23→ Common Stock (9 underlying)
9
Stock Option
Exercise: $3000.00Exp: 2028-10-29→ Common Stock (25 underlying)
25
Stock Option
Exercise: $5.08Exp: 2031-03-18→ Common Stock (293,479 underlying)
293,479
Common Stock
166,046
Stock Option
Exercise: $3000.00Exp: 2025-09-04→ Common Stock (6 underlying)
6
Stock Option
Exercise: $3000.00Exp: 2026-06-10→ Common Stock (15 underlying)
15
Stock Option
Exercise: $3000.00Exp: 2027-07-12→ Common Stock (20 underlying)
20

Footnotes (5)

[F1]Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
[F2]The option is currently exercisable.
[F3]The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
[F4]The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.
[F5]The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 with the remaining 53,381 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.

Documents

1 file